Ying, X., Che, X., Wang, J., Zou, G., Yu, Q., & Zhang, X. (2021). CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer. J Cancer.
Styl cytowania ChicagoYing, Xue, Xuan Che, Jianzhang Wang, Gen Zou, Qin Yu, i Xinmei Zhang. "CDK1 Serves As a Novel Therapeutic Target for Endometrioid Endometrial Cancer." J Cancer 2021.
Styl cytowania MLAYing, Xue, et al. "CDK1 Serves As a Novel Therapeutic Target for Endometrioid Endometrial Cancer." J Cancer 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..